STERIS plc — Director's Dealing 2019

Mar 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS Ltd (STE)
CIK: 0001757898
Period of Report: 2019-03-28

Reporting Person: KOSECOFF JACQUELINE B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-28	Ordinary Shares	A	42830	—	Acquired	42830	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-28	Director Stock Option (right to buy)	$28.08	A	3609	Acquired	2019-07-31	Ordinary Shares (3609)	Direct
2019-03-28	Director Stock Option (right to buy)	$32.34	A	3133	Acquired	2020-08-04	Ordinary Shares (3133)	Direct
2019-03-28	Director Stock Option (right to buy)	$31.61	A	3121	Acquired	2021-08-03	Ordinary Shares (3121)	Direct
2019-03-28	Director Stock Option (right to buy)	$32.36	A	3218	Acquired	2022-08-03	Ordinary Shares (3218)	Direct
2019-03-28	Director Stock Option (right to buy)	$43.92	A	4657	Acquired	2023-08-08	Ordinary Shares (4657)	Direct
2019-03-28	Director Stock Option (right to buy)	$51.53	A	4584	Acquired	2024-08-06	Ordinary Shares (4584)	Direct
2019-03-28	Director Stock Option (right to buy)	$64.05	A	4110	Acquired	2025-08-31	Ordinary Shares (4110)	Direct
2019-03-28	Director Stock Option (right to buy)	$71.40	A	3781	Acquired	2026-08-10	Ordinary Shares (3781)	Direct
2019-03-28	Director Stock Option (right to buy)	$86.23	A	927	Acquired	2027-08-09	Ordinary Shares (927)	Direct
2019-03-28	Director Stock Option (right to buy)	$114.74	A	436	Acquired	2028-08-09	Ordinary Shares (436)	Direct
2019-03-28	Career Restricted Stock Units	$	A	3184	Acquired		Ordinary Shares (3184)	Direct

Footnotes

F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees.

F3: This option to purchase 3,609 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F4: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F5: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F6: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F7: This option to purchase 4,657 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,657 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F8: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F9: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F10: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F11: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F12: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.